BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34502535)

  • 1. Increase in
    Huang PY; Yang YC; Wang CI; Hsiao PW; Chiang HI; Chen TW
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiota associated with high-Gleason prostate cancer.
    Matsushita M; Fujita K; Motooka D; Hatano K; Fukae S; Kawamura N; Tomiyama E; Hayashi Y; Banno E; Takao T; Takada S; Yachida S; Uemura H; Nakamura S; Nonomura N
    Cancer Sci; 2021 Aug; 112(8):3125-3135. PubMed ID: 34051009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Trends and Challenges of Microbiome Research in Prostate Cancer.
    Trecarten S; Fongang B; Liss M
    Curr Oncol Rep; 2024 May; 26(5):477-487. PubMed ID: 38573440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Gut Microbiota Profiles and Microbiota Steroid Hormone Biosynthesis in Men with and Without Prostate Cancer.
    Kalinen S; Kallonen T; Gunell M; Ettala O; Jambor I; Knaapila J; Syvänen KT; Taimen P; Poutanen M; Aronen HJ; Ollila H; Pietilä S; Elo LL; Lamminen T; Hakanen AJ; Munukka E; Boström PJ;
    Eur Urol Open Sci; 2024 Apr; 62():140-150. PubMed ID: 38500636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to comment: Revisiting the impact of antibiotics on prostate cancer risk: Beyond the gut microbiota.
    Park SJ; Park YJ; Park SM
    Int J Urol; 2024 Apr; 31(4):334. PubMed ID: 38361392
    [No Abstract]   [Full Text] [Related]  

  • 6. Revisiting the impact of antibiotics on prostate cancer risk: Beyond the gut microbiota.
    Lin YH; Chen YT; Tsai HY
    Int J Urol; 2024 Apr; 31(4):333. PubMed ID: 38284306
    [No Abstract]   [Full Text] [Related]  

  • 7. The Relationship between Gut Microbiota and Prostate Health.
    Pak SW; Shin YS; Park HJ
    World J Mens Health; 2024 Apr; ():. PubMed ID: 38772532
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials.
    Fukuokaya W; Mori K; Yanagisawa T; Akazawa K; Shimomura T; Kimura T
    Prostate Cancer Prostatic Dis; 2023 Jul; ():. PubMed ID: 37464102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome in modulating immune checkpoint inhibitors.
    Li X; Zhang S; Guo G; Han J; Yu J
    EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups.
    Hurst R; Meader E; Gihawi A; Rallapalli G; Clark J; Kay GL; Webb M; Manley K; Curley H; Walker H; Kumar R; Schmidt K; Crossman L; Eeles RA; Wedge DC; Lynch AG; Massie CE; ; Yazbek-Hanna M; Rochester M; Mills RD; Mithen RF; Traka MH; Ball RY; O'Grady J; Brewer DS; Wain J; Cooper CS
    Eur Urol Oncol; 2022 Aug; 5(4):412-419. PubMed ID: 35450835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut environment changes due to androgen deprivation therapy in patients with prostate cancer.
    Kure A; Tsukimi T; Ishii C; Aw W; Obana N; Nakato G; Hirayama A; Kawano H; China T; Shimizu F; Nagata M; Isotani S; Muto S; Horie S; Fukuda S
    Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):323-330. PubMed ID: 35418210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiosis Signature of Fecal Microbiota in Patients with Pancreatic Adenocarcinoma and Pancreatic Intraductal Papillary Mucinous Neoplasms.
    Sidiropoulos T; Dovrolis N; Katifelis H; Michalopoulos NV; Kokoropoulos P; Arkadopoulos N; Gazouli M
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38791002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and overcoming resistance to immunotherapy in genitourinary cancers.
    Evans ST; Jani Y; Jansen CS; Yildirim A; Kalemoglu E; Bilen MA
    Cancer Biol Ther; 2024 Dec; 25(1):2342599. PubMed ID: 38629578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraprobiotic derived from
    Lee HJ; Tran MTH; Le MH; Justine EE; Kim YJ
    Front Immunol; 2024; 15():1285063. PubMed ID: 38455053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
    Zha C; Peng Z; Huang K; Tang K; Wang Q; Zhu L; Che B; Li W; Xu S; Huang T; Yu Y; Zhang W
    Front Oncol; 2023; 13():1196217. PubMed ID: 37265797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the Human Microbiome and Its Connections with Prostate Cancer.
    Munteanu R; Feder RI; Onaciu A; Munteanu VC; Iuga CA; Gulei D
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human microbiome links to prostate cancer risk and treatment (Review).
    Xia B; Wang J; Zhang D; Hu X
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37144511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating androgen regulation by androgen-catabolizing gut bacteria in male mouse gut.
    Hsiao TH; Chou CH; Chen YL; Wang PH; Brandon-Mong GJ; Lee TH; Wu TY; Li PT; Li CW; Lai YL; Tseng YL; Shih CJ; Chen PH; Chen MJ; Chiang YR
    Gut Microbes; 2023; 15(1):2183685. PubMed ID: 36843073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Radium-223 on the Gut Microbiota of Prostate Cancer Patients: A Pilot Case Series Study.
    Fernandes A; Oliveira A; Guedes C; Fernandes R; Soares R; Barata P
    Curr Issues Mol Biol; 2022 Oct; 44(10):4950-4959. PubMed ID: 36286051
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.